We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+11.35%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$81.6B
AUM Growth
+$7.7B
Cap. Flow
+$798M
Cap. Flow %
0.98%
Top 10 Hldgs %
23.85%
Holding
3,095
New
53
Increased
1,513
Reduced
1,408
Closed
84

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$65.3M
2
AMZN icon
Amazon
AMZN
+$50M
3
TSLA icon
Tesla
TSLA
+$30.5M
4
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$26.6M
5
EPAM icon
EPAM Systems
EPAM
+$26.3M

Sector Composition

Rank Sector Weight
1 Technology 25.54%
2 Financials 13.15%
3 Healthcare 12.95%
4 Consumer Discretionary 12.27%
5 Industrials 8.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
STRL icon
2201
Sterling Infrastructure
STRL
$16.7B
$1.01M ﹤0.01%
38,550
-405
-1% -$10.4K
MDGL icon
2202
Madrigal Pharmaceuticals
MDGL
$11.8B
$1.01M ﹤0.01%
11,942
-171
-1% -$14K
CMRE icon
2203
Costamare
CMRE
$1.77B
$1.01M ﹤0.01%
79,924
-51
-0.1% -$667
HONE
2204
DELISTED
HarborOne Bancorp
HONE
$1.01M ﹤0.01%
67,925
-232
-0.3% -$3.37K
SWBI icon
2205
Smith & Wesson
SWBI
$637M
$1.01M ﹤0.01%
56,523
-14
-0% -$289
TIL icon
2206
Instil Bio
TIL
$50.3M
$1.01M ﹤0.01%
2,939
+2,087
+245% +$806K
BLNK icon
2207
Blink Charging
BLNK
$87.9M
$1M ﹤0.01%
37,917
-626
-2% -$20.2K
CPRX
2208
DELISTED
Catalyst Pharmaceutical
CPRX
$1M ﹤0.01%
148,483
-1,089
-0.7% -$7.16K
RYAM icon
2209
Rayonier Advanced Materials
RYAM
$610M
$1M ﹤0.01%
175,635
+1,412
+0.8% +$9.18K
SPNS
2210
DELISTED
Sapiens International
SPNS
$1M ﹤0.01%
29,018
-561
-2% -$19.3K
BFLY icon
2211
Butterfly Network
BFLY
$2.35B
$998K ﹤0.01%
149,164
-27,310
-15% -$240K
NEX
2212
DELISTED
NexTier Oilfield Solutions Inc.
NEX
$997K ﹤0.01%
280,905
+680
+0.2% +$2.85K
PLOW icon
2213
Douglas Dynamics
PLOW
$1.02B
$996K ﹤0.01%
25,493
-463
-2% -$18.7K
LASR icon
2214
nLIGHT
LASR
$3.17B
$994K ﹤0.01%
41,512
-327
-0.8% -$8.63K
RRD
2215
DELISTED
RR Donnelley & Sons Co.
RRD
$991K ﹤0.01%
88,031
+4,365
+5% +$37.8K
GDEN
2216
DELISTED
Golden Entertainment
GDEN
$988K ﹤0.01%
19,559
-390
-2% -$19.3K
OIS icon
2217
Oil States International
OIS
$491M
$987K ﹤0.01%
198,646
+6,326
+3% +$37.2K
AMBP icon
2218
Ardagh Metal Packaging
AMBP
$3.01B
$986K ﹤0.01%
+109,223
New +$1.04M
MORF
2219
DELISTED
Morphic Holding, Inc. Common Stock
MORF
$986K ﹤0.01%
20,800
+480
+2% +$25.7K
UFI icon
2220
UNIFI
UFI
$134M
$985K ﹤0.01%
42,549
+328
+0.8% +$7.48K
PGC icon
2221
Peapack-Gladstone Financial
PGC
$812M
$984K ﹤0.01%
27,799
-345
-1% -$11.8K
AEVA
2222
Aeva Technologies
AEVA
$1.86B
$981K ﹤0.01%
25,943
+7,520
+41% +$316K
ASPN icon
2223
Aspen Aerogels
ASPN
$518M
$981K ﹤0.01%
19,707
+119
+0.6% +$6.27K
ALHC icon
2224
Alignment Healthcare
ALHC
$2.98B
$974K ﹤0.01%
69,307
+47,520
+218% +$832K
BLUE
2225
DELISTED
bluebird bio
BLUE
$974K ﹤0.01%
4,874
-2,731
-36% -$644K

Similar funds

RhumbLine Advisers's Q4 2021 Portfolio in Review

As of Q4 2021, RhumbLine Advisers held 3,095 positions worth $81.6B, up 10% from $73.9B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Trading was light in Q4 2021: portfolio turnover was 4.4%. RhumbLine Advisers opened 53 new positions and exited 84, leaving the 3,095-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 24% a quarter earlier, followed by Financials and Healthcare.

  • RhumbLine Advisers's largest Q4 2021 buy was Rivian: 125,331 shares worth $13M.
  • RhumbLine Advisers added most to Microsoft in Q4 2021, an estimated $65.3M increase.
  • RhumbLine Advisers's biggest Q4 2021 reduction was Berkshire Hathaway Class B, cutting an estimated $21.9M.
  • RhumbLine Advisers fully exited Kansas City Southern in Q4 2021, selling an estimated $39.1M.
  • RhumbLine Advisers's ten largest holdings make up 24% of its $81.6B portfolio in Q4 2021.
  • RhumbLine Advisers opened 53 new positions and closed 84 in Q4 2021.
  • RhumbLine Advisers's portfolio value rose 10% quarter-over-quarter to $81.6B.

Based on RhumbLine Advisers's 13F filing for Q4 2021, filed 10 Feb 2022.